Tumor immunotherapy exerts its anti-tumor effects by stimulating and enhancing immune
responses of the body. It has become another important modality of anti-tumor therapy with …

Hematologic malignancies (HMs) pose a serious threat to patients' health and life, and the
five-year overall survival of HMs remains low. The lack of understanding of the pathogenesis …

Immune checkpoint blockade has emerged as a significant therapeutic development in
immunotherapy during the past decade. However, only a small percentage of cancer …

Rheumatoid arthritis (RA), a systemic autoimmune disease, poses a significant human
health threat. Iguratimod (IGUR), a novel disease‐modifying antirheumatic drug (DMARD) …

Non-obese diabetic (NOD) mice were taken as primary Sjögren's syndrome (pSS) model
mice to examine the therapeutic impact of iguratimod (IGU) on inflammatory factors levels …

Currently, multiple myeloma (MM) is a prevalent hematopoietic system malignancy, known
for its insidious onset and unfavorable prognosis. Recently developed chemotherapy drugs …

Apoptosis is the cell's natural intrinsic regulatory mechanism of normal cells for programmed
cell death, which plays an important role in cancer as a classical mechanism of tumor cell …

Glioblastoma (GBM) remains a challenging malignancy due to its aggressive nature and the
lack of efficacious therapeutic interventions. Nanotechnology-based approaches exhibit …

WITHDRAWN: Long non-coding RNA RP5-821D11.7 promotes proliferation, migration, and
epithelial-mesenchymal transition in glioma and glioma stem-like cells - ScienceDirect Skip …

Background The main reasons pancreatic cancer (PC) is difficult to treat are high tissue
fibrosis and a strong immunosuppressive microenvironment. Therefore, it is necessary to …